Overview of Spineway's Upcoming General Meeting
Spineway is gearing up for an exciting milestone as it invites all shareholders to its Combined General Meeting scheduled for Wednesday, June 4, 2025, at 2:00 p.m. The meeting will take place at the company headquarters, which holds significant importance for both the company and its stakeholders.
Details for Shareholder Participation
The notice for this Combined General Meeting includes crucial elements such as the agenda and the text of resolutions planned for discussion. Shareholders can find this important information in the notice published in the Bulletin des Annonces Légales Obligatoires (BALO) dated April 30, 2025. This publication serves as an official convocation notice, ensuring that all necessary details on participating and voting during the meeting are easily accessible.
Document Access and Information Availability
In a world where transparency is vital, Spineway has made the meeting notice and all related documents easily accessible. These are available on the company's website under the "Investors/Regulated Information" section. This ensures that shareholders are well-informed and can prepare appropriately ahead of the meeting.
Next Important Dates
Mark your calendars for pivotal dates related to Spineway's financial journey. Following the General Meeting on June 4, there’s also the release of H1 2025 revenue on July 30. These dates are crucial for tracking the company's performance and strategic direction.
Spineway's Professional Commitment
Spineway is recognized for its dedication to advancing healthcare solutions. The company designs, manufactures, and markets innovative implants and surgical instruments aimed at treating severe spinal disorders. With an international network of over 50 independent distributors and a remarkable 70% of revenue derived from exports, Spineway is positioned as a global leader in spinal treatment innovations.
Eligibility for Equity Savings Plans
As an added advantage, Spineway is eligible for PEA-SME (Equity Savings Plans for SMEs), making it an attractive option for investors looking into growth opportunities in the healthcare sector.
How to Reach Spineway
If shareholders or interested parties have any questions or require further information, they can easily reach out through the shareholder-services line. Available from Tuesday to Thursday, the line provides direct access to customer service representatives who are ready to assist.
Contact Information
For inquiries related to investor relations, stakeholders can get in touch with Solène Kennis at AELIUM. This dedicated support aims to maintain open lines of communication with investors and stakeholders alike.
Frequently Asked Questions
What is the date and time of Spineway's General Meeting?
The Combined General Meeting is scheduled for June 4, 2025, at 2:00 p.m.
Where is the General Meeting taking place?
The meeting will be held at Spineway's headquarters.
How can shareholders access meeting documents?
Documents are available on the company's website under the "Investors/Regulated Information" section.
What is Spineway's focus in the healthcare industry?
Spineway specializes in designing and manufacturing innovative implants and surgical instruments for spinal disorders.
How can investors contact Spineway for more information?
Investors can reach Spineway's shareholder-services line or contact Solène Kennis at AELIUM for investor relations inquiries.
